Diversion Issues Sample Clauses

Diversion Issues. All Product delivered to Purchaser shall be: (a) stored securely by Purchaser; and (b) distributed by Purchaser only in Albania in a secure manner appropriate to the transportation route and destination, in each case (a) and (b) to guard against and deter theft, diversion, tampering, substitution (with, for example, counterfeits) resale or export out of Albania, and to protect and preserve the integrity and efficacy of the Product. Purchaser shall promptly notify Pfizer by email1 within 48 hours (with follow up in writing in line with the notice provisions of this Agreement) if at any time Purchaser believes that any of the Product has been stolen, diverted, tampered with, substituted, or otherwise 1Note to Draft: To include quality/diversion notice contact information. subjected to abuse, misuse, neglect, negligence, accident, improper testing, improper storage, improper handling, abnormal physical stress, abnormal environmental conditions or use contrary to any instructions issued by Pfizer. The notice shall provide all information relating to the Product diversion, including, but not limited to, detailed information including the date, time, location, number, batch number(s), expiration date, circumstances, and contact person(s) information. Purchaser shall cooperate with Pfizer or its designee, upon Pfizer’s request, to cooperate in connection with such Product diversion.
Sample 1Sample 2Sample 3See All (6)
AutoNDA by SimpleDocs
Diversion Issues. All Product delivered to Purchaser shall be: (a) stored securely by Purchaser; and (b) distributed by Purchaser only in Colombia in a secure manner appropriate to the transportation route and destination, in each case (a) and (b) to guard against and deter theft, diversion, tampering, substitution (with, for example, counterfeits) resale or export out of Colombia, and to protect and preserve the integrity and efficacy of the Product. Purchaser shall promptly notify Pfizer by email within 48 hours (with fo low up in writing with the notice provisions of this Agreement) if at any time Purchaser believesthat any b) Pfizer analizará las causas de tales reclamos por calidad e informará al Comprador las medidas correctivas adoptadas. Si la inspección y las pruebas de Pfizer revelan, a satisfacción razonable de Pfizer, que esos ítems del Producto constituyen Producto No Conforme y que esa no conformidad o defecto no ha sido causada o aumentada por abuso, uso indebido, descuido, negligencia, accidente, prueba, almacenamiento o manipulación indebida, tensión física o condiciones medioambientales anormales o uso contrario a cualquiera de las instrucciones impartidas por Pfizer, Pfizer empleará los Esfuerzos Comercialmente Razonables para reemplazar ese Producto No Conforme tan pronto como sea posible, sin lugar a cobro adicional al Comprador. En esas circunstancias, Pfizer gestionará la logística de recogida y destrucción del Producto No Conforme. Hasta que tenga lugar su recogida, el Comprador almacenará y mantendrá debidamente el Producto No Conforme de que se trate en lugares seguros y de acuerdo con las especificacionesde los fabricantes. No obstante, cualquier otra disposición de este Acuerdo, esta Sección 4.4(b) contempla el recurso único y exclusivo del Comprador respecto del Producto No Conforme. Las disposiciones de esta Sección 4.4 (Rechazo del Producto; Destrucción de los Envíos Rechazados) subsistirán a la terminación o vencimiento de este Acuerdo.
Sample 1Sample 2See All (4)
Diversion Issues. Gilead shall be responsible for developing and implementing all procedures necessary to prevent the diversion of Product from the waste stream in the course of Manufacture, including the rendering of the Product unsaleable.
Sample 1Sample 2
Diversion Issues. Gilead agrees to immediately notify Eyetech if at any time it believes that any Product has been lost or stolen from the Facility, or any quantities of Product that have been rendered unsaleable while in Gilead's possession.
Sample 1Sample 2
Diversion Issues. All Product delivered to a Participating Member State shall be: (a) stored securely by the Participating Member State; and (b) without prejudice to Article I.6.2, distributed by the Participating Member State in a secure manner appropriate to the transportation route and destination, in each case (a) and (b) to guard against and deter theft, diversion, tampering, substitution (with, for example, counterfeits) or unauthorised resale or export out of the Participating Member State, and to protect and preserve the integrity and efficacy of the Product. [***]
Sample 1
Diversion Issues. Supplier shall promptly notify Customer if at any time Supplier believes that any Product Deliverable has been lost or stolen, or any Product Deliverable has been rendered unsalable.
Sample 1
Diversion Issues. Ustanovenia týkajúce sa presmerovania. All Product delivered to Purchaser shall be: (a) stored securely by Purchaser; and (b) without prejudice to Section Chyba! Nenašiel sa žiaden zdroj odkazov. of this Agreement, distributed by Purchaser in a secure manner appropriate to the transportation route and destination, in each case (a) and (b) to guard against and deter theft, diversion, tampering, substitution (with, for example, counterfeits) or unauthorized resale or export out of the Jurisdiction, and to protect and preserve the integrity and efficacy of the Product. Purchaser shall promptly notify Pfizer in writing (and in any event within 48 hours) if at any time Purchaser believes or becomes aware that any of the Product has been stolen, diverted, tampered with, substituted, or otherwise subjected to abuse, misuse, neglect, negligence, accident, improper testing, improper storage, improper handling, abnormal physical stress, abnormal environmental conditions or use contrary to any instructions issued by Pfizer. The notice Všetky Produkty dodávané Kupujúcemu musia byť: (a) Kupujúcim bezpečne skladované; a (b) bez toho aby bol dotknutý článok Chyba! Nenašiel sa žiaden zdroj odkazov. tejto Zmluvy, distribuované Kupujúcim bezpečným spôsobom zodpovedajúcim prepravnej trase a miestu určenia, a to v prípade (a) aj (b) tak, aby bola zaistená ochrana pred krádežou, presmerovaním, neoprávnenou manipuláciou, zámenou (napr. za falzifikáty) alebo neoprávneným ďalším predajom alebo vývozom mimo Jurisdikciu a aby bola chránená a zachovaná integrita a účinnosť Produktu. Kupujúci je povinný okamžite (v každom prípade do 48 hodín) písomne oboznámiť spoločnosť Pfizer, ak sa bude Kupujúci kedykoľvek domnievať alebo zistí, že akýkoľvek Produkt bol odcudzený, presmerovaný, bolo s ním neoprávnene manipulované, bol zamenený či bol vystavený alebo inak došlo k zneužitiu, nesprávnemu použitiu, zanedbaniu, nedbalosti, nehode, shall provide all information relating to the Product diversion, including, but not limited to, detailed information including the date, time, location, number, batch number(s), expiration date, circumstances, and contact person(s) information. Purchaser shall cooperate with Pfizer or its designee, upon Pfizer’s request, in connection with such Product diversion. Except for further distribution in the Jurisdiction permitted in accordance with this Agreement and subject to Section Chyba! Nenašiel sa žiaden zdroj odkazov. of this Agreement, Purchaser shall not ...
Sample 1
AutoNDA by SimpleDocs
Diversion Issues. All Product delivered to a Participating Member State shall be: (a) stored securely by the Participating Member State; and (b) without prejudice to Article I.6.2, distributed by the Participating Member State in a secure manner appropriate to the transportation route and destination, in each case (a) and (b) to guard against and deter theft, diversion, tampering, substitution (with, for example, counterfeits) or unauthorised resale or export out of the Participating Member State, and to protect and preserve the integrity and efficacy of the Product. [***] SANTE/2020/C3/043 - SI2.838335 I. 7 PRICES The price of the Vaccine to the Commission and the Participating Member States for the 200 million Contracted Doses will be [***] [***] [***] [***] [***] [***] [***] [***] [***]
Sample 1

Related to Diversion Issues

  • Clinical 1.1 Provides comprehensive evidence based nursing care and individual case management to a specific group of patients/clients including assessment, intervention and evaluation. 1.2 Undertakes clinical shifts at the direction of senior staff and the Nursing Director including participation on the on-call/after-hours/weekend roster if required. 1.3 Responsible and accountable for patient safety and quality of care through planning, coordinating, performing, facilitating, and evaluating the delivery of patient care relating to a particular group of patients, clients or staff in the practice setting. 1.4 Monitors, reviews and reports upon the standard of nursing practice to ensure that colleagues are working within the scope of nursing practice, following appropriate clinical pathways, policies, procedures and adopting a risk management approach in patient care delivery. 1.5 Participates in xxxx rounds/case conferences as appropriate. 1.6 Educates patients/carers in post discharge management and organises discharge summaries/referrals to other services, as appropriate. 1.7 Supports and liaises with patients, carers, colleagues, medical, nursing, allied health, support staff, external agencies and the private sector to provide coordinated multidisciplinary care. 1.8 Completes clinical documentation and undertakes other administrative/management tasks as required. 1.9 Participates in departmental and other meetings as required to meet organisational and service objectives. 1.10 Develops and seeks to implement change utilising expert clinical knowledge through research and evidence based best practice. 1.11 Monitors and maintains availability of consumable stock. 1.12 Complies with and demonstrates a positive commitment to Regulations, Acts and Policies relevant to nursing including the Code of Ethics for Nurses in Australia, the Code of Conduct for Nurses in Australia, the National Competency Standards for the Registered Nurse and the Poisons Act 2014 and Medicines and Poisons Regulations 2016. 1.13 Promotes and participates in team building and decision making. 1.14 Responsible for the clinical supervision of nurses at Level 1 and/or Enrolled Nurses/ Assistants in Nursing under their supervision.

  • Diversion In case, the contractor is directed in writing by an Officer of NFL and / or the authorized warehouse in- charge to carry the material further to any other destination after reaching the original destination as per the Delivery challan, the contractor, would carry out such instructions. The payment of such diverted delivery of material will be the same as if it is direct delivery to the final destination.

  • Diversity The Employer and the Union recognize the values of diversity in the workplace and will work cooperatively toward achieving a work environment that reflects the interests of a diverse work force.

  • Grievability Denial of a petition for reinstatement is grievable. The grievance may not be based on information other than that shared with the Employer at the time of the petition for reinstatement.

  • Client Classification 7.1. We shall not have an obligation to treat our clients in different classes depending on their knowledge and expertise.

  • Classification Review (A) Reclassification Request (a) An employee who has good reason to believe that they are improperly classified may apply, in writing by electronic mail, to their immediate out-of-scope Manager to have their classification reviewed. This may occur when there has been a substantive change in the job functions, when there has been a change in organizational structure that significantly impacts roles, or when a classification specification has been amended in a manner that alters the basis on which classification levels are differentiated. The employee making the request will indicate the reason(s) why they believe their position is inappropriately classified, including the changes that have occurred to the position, organization or classification specifications. In some circumstances, a classification review may be initiated in response to a long standing perceived inequity in how a position is classified. However, where a review has been previously conducted, employees should not request a subsequent classification review unless there has been a substantive change as described above. Submissions must include an approved job description, in the event that a current job description is not available an employee can initiate their written request so as to establish a potential effective date as per article 40.04(a). The manager shall send a copy of the employee’s request to Human Resources without delay, and shall confirm in writing to the employee and the Union that the employee’s request has been received. The manager shall advise the employee of the results of the classification review within ninety (90) calendar days of receiving the request. The notification shall be in writing and include rationale for the decision, specifically addressing the reasons for the review provided by the employee. (b) When reviewing a request for reclassification, the Employer shall follow the guidelines included in the Classification Specification User Manual. Requests are reviewed by the Employer. The evaluation of the role may include an audit of the role, including interviews with the Employee and the Employee’s Manager as needed. (c) Should the employee feel that they have not received proper consideration in regard to a classification review, they may request that the matter be referred to the Internal Appeal Process.

  • Benchmarking 19.1 The Parties shall comply with the provisions of Framework Schedule 12 (Continuous Improvement and Benchmarking) in relation to the benchmarking of any or all of the Goods and/or Services.

  • TECHNICAL EVALUATION (a) Detailed technical evaluation shall be carried out by Purchase Committee pursuant to conditions in the tender document to determine the substantial responsiveness of each tender. For this clause, the substantially responsive bid is one that conforms to all the eligibility and terms and condition of the tender without any material deviation. The Institute’s determination of bid’s responsiveness is to be based on the contents of the bid itself without recourse to extrinsic evidence. The Institute shall evaluate the technical bids also to determine whether they are complete, whether required sureties have been furnished, whether the documents have been properly signed and whether the bids are in order. (b) The technical evaluation committee may call the responsive bidders for discussion or presentation to facilitate and assess their understanding of the scope of work and its execution. However, the committee shall have sole discretion to call for discussion / presentation. (c) Financial bids of only those bidders who qualify the technical criteria will be opened provided all other requirements are fulfilled. (d) AIIMS Jodhpur shall have right to accept or reject any or all tenders without assigning any reasons thereof.

  • Orally Administered Anticancer Medication In accordance with RIGL § 27-20-67, prescription drug coverage for orally administered anticancer medications is provided at a level no less favorable than coverage for intravenously administered or injected cancer medications covered under your medical benefit.

  • Appropriate Safeguards BA shall implement appropriate safeguards to prevent the use or disclosure of Protected Information other than as permitted by the Contract or Addendum, including, but not limited to, administrative, physical and technical safeguards in accordance with the Security Rule, including, but not limited to, 45 C.F.R. Sections 164.308, 164.310, and 164.312. [45 C.F.R. Section 164.504(e)(2)(ii)(B); 45 C.F.R. Section 164.308(b)]. BA shall comply with the policies and procedures and documentation requirements of the Security rule, including, but not limited to, 45 C.F.R. Section 164.316 [42 U.S.C. Section 17931].

Draft better contracts in just 5 minutes Get the weekly Law Insider newsletter packed with expert videos, webinars, ebooks, and more!